Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats

Journal of Immunology

Volumn 168, Issue 1, 2002, Pages 450-457

  Yamashita, A ^a   Yonemitsu, Y ^a   Okano, S ^a   Nakagawa, K ^a   Nakashima, Y ^a   Irisa, T ^a   Iwamoto, Y ^a   Nagai, Y ^a   Hasegawa, M ^a   Sueishi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR 2; IMMUNOGLOBULIN G; POLYPEPTIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; BONE DESTRUCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GENE OVEREXPRESSION; GENE TRANSFER; HISTOPATHOLOGY; INFLAMMATION; JOINT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; RHEUMATOID ARTHRITIS; SENDAI VIRUS;

EID: 0036135611     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.1.450     Document Type: Article

References (48)

1. Rheumatoid arthritis: Pathophysiology and implications for therapy
2. Etiology and pathogenesis of rheumatoid arthritis
3. A review of the histopathological evidence on the pathogenesis of cartilage destruction in rheumatoid arthritis
4. The inflammatory arthritides
5. Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA
6. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis
7. In vivo model of cartilage degradation: Effects of a matrix metalloproteinase inhibitor
8. Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis
9. Angiogenesis: A critical process in the pathogenesis of RA: A role for VEGF?
10. Angiogenesis in pannus formation
11. Angiogenesis and rheumatoid arthritis: Pathogenic and therapeutic implications
12. Target effector role of vascular endothelium in the inflammatory response: Insights from the clinical trial of anti-TNFγ antibody in rheumatoid arthritis
13. Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients
14. Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis
15. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
16. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis
17. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
18. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis
19. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice
20. Immunolocalization of basic fibroblast growth factor and platelet-derived growth factor-A during adjuvant arthritis in the Lewis rat
21. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease
22. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis
23. Effects of acid and basic fibroblast growth factor and heparin on resorption of cultured fetal rat long bones
24. Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures
25. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures
26. Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase
27. Recombinant Sendai virus-mediated gene transfer to vasculature: A new class of efficient gene transfer vector to the vascular system
28. Efficient gene transfer to airway epithelium using recombinant Sendai virus
29. Revised criteria for the classification of rheumatoid arthritis
30. Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year
31. Aminobisphosphonate (YM175) inhibits bone destruction in rat adjuvant arthritis
32. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense
33. Accommodation of foreign genes into the Sendai virus genome: Sizes of inserted genes and viral replication
34. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: The rule of six revisited
35. Hemagglutinating virus of Japan liposomemediated gene delivery to vascular cells
36. Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (hemagglutinating virus of Japan) liposomes: An effective tool for the in vivo study of arterial diseases
37. The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo
38. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo
39. Studies on the chronic phase of adjuvant arthritis: Effect of SR 41319, a new diphosphonate
40. ++ system: A new immunohistochemical method for diagnostics and research: Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques
41. Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover
42. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints
43. Serious adverse effect of intramuscular gene transfer of VEGF165 for limb salvage in mice with critical limb ischemia
44. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines
45. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
46. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism
47. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion
48. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis